Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
30.56
+0.05 (0.16%)
At close: Apr 28, 2026, 4:00 PM EDT
30.56
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:48 PM EDT
Rigel Pharmaceuticals Employees
As of December 31, 2025, Rigel Pharmaceuticals had 174 total employees, including 172 full-time and 2 part-time employees. The number of employees increased by 10 or 6.10% compared to the previous year.
Employees
174
Change (1Y)
10
Growth (1Y)
6.10%
Revenue / Employee
$1,691,276
Profits / Employee
$2,109,333
Market Cap
564.75M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ProKidney | 231 |
| Sutro Biopharma | 137 |
| Kyverna Therapeutics | 130 |
| Ocugen | 116 |
| Adlai Nortye | 109 |
| Prothena Corporation | 67 |
| Zevra Therapeutics | 61 |
| Tectonic Therapeutic | 60 |
RIGL News
- 11 hours ago - Rigel Announces Conference Call and Webcast to Report First Quarter 2026 Financial Results - PRNewsWire
- 21 days ago - Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 4 weeks ago - Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology - PRNewsWire
- 2 months ago - Rigel Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - PRNewsWire
- 2 months ago - Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update - PRNewsWire
- 3 months ago - Rigel Appoints Michael P. Miller to the Board of Directors - PRNewsWire
- 3 months ago - Rigel Pharmaceuticals Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts